A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group.

A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group

The citation for this report is:
Schulman KL, Berenson K, Shih YC, et al. A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group. Value Health 2013;16:655-69

Co-chairs:

Karina Berenson, MPH, Associate Director, Global Health Economics & Pricing, Covance, Gaithersburg, MD, USA
Kathy L. Schulman, MA, Principal, Outcomes Research Solutions, Inc., Boston, MA, USA

Leadership Group:

Stella Chang, MPH, Director, Thomson Reuters, Washington, DC, USA
Jonas de Souza, MD, Oncology Clinical Fellow, University of Chicago, Chicago, IL, USA
Donatus U. Ekwueme, PhD, MA, Senior Health Economist, CDC, Sandy Springs, GA, USA
Arijit Ganguli, MBA, Manager Oncology, Abbott Laboratories, Abbot Park, IL, USA
Lenka Kellerman, MBA, Managing Director, Oncology Information Services, Freiburgi.Br., Germany
Ya-Chen (Tina) Shih, PhD, Associate Professor, Section of Hospital Medicine, Department of Medicine, Director, Program in Economics of Cancer University of Chicago, Chicago, IL, USA
Alex Shteynshlyuger MD, Fellow, Urologic Oncology, Washington University in St Louis, St Louis, MO, USA
Samuel Wagner, PhD, RPh, MSc, BSc, Executive Director, HEOR, Bristol Myers Squibb, Washington Crossing, PA, USA


Oncology Special Interest Group | Special Interest Groups Index